Elevance Health: Bearish Outlook Despite Q3 Gains
Update: 2025-11-27
Description
Elevance Health, a major healthcare benefits provider, has seen mixed performance recently. Despite a nine point two percent gain over the past three months, outpacing the Nasdaq, its stock has dropped over twenty-six percent from its peak in April. The companys stock has underperformed the broader Nasdaq market year-to-date and over the past year. Elevance reported a twelve percent revenue increase in its third-quarter results, but adjusted earnings per share dropped by nearly thirty percent. Analysts have a Moderate Buy rating on the stock, suggesting a twelve point one percent upside potential.
The Daily News Now! — Every city. Every story. AI-powered.
Hosted on Acast. See acast.com/privacy for more information.
Comments
In Channel
Download from Google Play
Download from App Store
United States00:00
00:00
1.0x
